Publications by authors named "Manuel Rodrigues"

Claim this Profile
A
An overview of the contaminant mixtures present in key consumed fish and seafood species along the Portuguese territory.
Filipe Costa, Manuel J Rodrigues, Filipe Martinho, Maria E Pereira, Miguel A Pardal

Mar Pollut Bull· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic Background Predicts Uveal Melanoma Patients' Outcomes.
Thibault Verrier, Anaïs Le Ven, Alexandre Houy, Erwin Brosens, Emine Kilic, Manuel Rodrigues

Ophthalmol Sci· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The combination of avutometinib and defactinib in treating recurrent low-grade serous ovarian cancer: a plain language summary of the Phase II clinical trial ENGOT-OV60/GOG-3052/RAMP 201.
Susana N Banerjee, Els Van Nieuwenhuysen, Carol Aghajanian, Véronique D'Hondt, Bradley J Monk, Manuel Rodrigues

Future Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic advances and molecular insights in low-grade serous ovarian carcinoma.
Rayan Kabirian, Thomas Gaillard, Diana Bello-Roufai, Caroline Malhaire, Virginie Huchet, Manuel Rodrigues

Bull Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[A 2025 inventory in oncology news].
Stéphane Vignot, Audrey Bellesoeur, Delphine Borchiellini, Carole Bouleuc, Romain Cohen, Manuel Rodrigues

Bull Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of metastatic uveal melanoma: French expert consensus guidelines.
Manuel Rodrigues, Vincent Servois, Pascale Mariani, Marc Pracht, Caroline Dutriaux

Bull Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Pembrolizumab with chemoradiotherapy in high risk locally advanced cervical cancer].
Mathilde Haberstich, Manuel Rodrigues

Bull Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum: Efficacy and Safety of Avutometinib ± Defactinib in Recurrent Low-Grade Serous Ovarian Cancer: Primary Analysis of ENGOT-OV60/GOG-3052/RAMP 201.
Susana N Banerjee, Els Van Nieuwenhuysen, Carol Aghajanian, Véronique D'Hondt, Bradley J Monk, Manuel Rodrigues

J Clin Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[How do doctors communicate results of genomic testing and its prognostic impact on uveal melanoma patients? Results of a qualitative study].
Anita Müller, Pauline Vaflard, Marie-France Mamzer, Nathalie Cassoux, Anne Bredart, Manuel Rodrigues

Bull Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between molecular classification and overall survival in patients with metastatic endometrial carcinoma: ancillary results of the UTOLA phase II GINECO trial.
Guillaume Beinse, Karen Leroy, Pierre-Alexandre Just, Corinne Jeanne, François Cherifi, Manuel Rodrigues

Int J Gynecol Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Mirvetuximab soravtansine as monotherapy in platinum-resistant ovarian cancer expressing alpha folate receptor].
Mathilde Reich, Manuel Rodrigues

Bull Cancer· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of platinum-free interval (PFI) and maintenance therapies in recurrent ovarian cancer to explain survival. An analysis from the French real-world ESME Ovarian Database.
Claire Chator, Marion Chevrier, Jean-Sébastien Frenel, Frédéric Guyon, Renaud Sabatier, Manuel Rodrigues

Gynecol Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[TRANSFORM-O: A new training program in translational research offered by the French Society of Cancer (SFC) and the French National College of Oncology Teachers (CNEC)].
Stanislas Quesada, Camille Tlemsani, Christophe Massard, Manuel Rodrigues

Bull Cancer· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Durvalumab and Olaparib Combination - First-line metastatic endometrial cancer].
Annabelle Sabouret, Manuel Rodrigues

Bull Cancer· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[End of life: Hearing the fears].
Manuel Rodrigues

Bull Cancer· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Avutometinib ± Defactinib in Recurrent Low-Grade Serous Ovarian Cancer: Primary Analysis of ENGOT-OV60/GOG-3052/RAMP 201.
Susana N Banerjee, Els Van Nieuwenhuysen, Carol Aghajanian, Véronique D'Hondt, Bradley J Monk, Manuel Rodrigues

J Clin Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-life data on tebentafusp in metastatic uveal melanoma patients from four EURACAN Expert Centres.
Monique K van der Kooij, Ellen Kapiteijn, Piotr Rutkowski, Jean-François Baurain, Leanne de Koning, Manuel Rodrigues

Eur J Cancer· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Uveal Melanoma and the Lynch Syndrome Tumor Spectrum.
Anaïs Le Ven, Marie-Charlotte Villy, André Bortolini Silveira, Alexandre Houy, Julien Masliah-Planchon, Manuel Rodrigues

JAMA Ophthalmol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maintenance olaparib after platinum-based chemotherapy for advanced/metastatic endometrial cancer: GINECO randomized phase IIb UTOLA trial.
Florence Joly, Alexandra Leary, Isabelle Ray-Coquard, Bernard Asselain, Manuel Rodrigues

Nat Commun· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Base-excision repair pathway shapes 5-methylcytosine deamination signatures in pan-cancer genomes.
André Bortolini Silveira, Alexandre Houy, Olivier Ganier, Begüm Özemek, Sandra Vanhuele, Manuel Rodrigues

Nat Commun· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Through Silicon MEMS Inspection with a Near-Infrared Laser Scanning Setup.
Manuel J L F Rodrigues, Inês S Garcia, Joana D Santos, Filipa C Mota, Filipe S Alves

Sensors (Basel)· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Pembrolizumab or dostarlimab in association to chemotherapy in advanced endometrial cancer].
Pierre Grassi, Manuel Rodrigues

Bull Cancer· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PARP inhibitors as maintenance therapy in ovarian cancer after platinum-sensitive recurrence: real-world experience from the Unicancer network.
Nicolas Rippstein, Christophe Zemmour, Manuel Rodrigues, Isabelle Ray-Coquard, Laurence Gladieff

Oncologist· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Olaparib combined to metronomic cyclophosphamide and metformin in women with recurrent advanced/metastatic endometrial cancer: the ENDOLA phase I/II trial.
Max Piffoux, Alexandra Leary, Philippe Follana, Cyril Abdeddaim, Florence Joly, Manuel Rodrigues

Nat Commun· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early palliative care in metastatic uveal melanoma (early together): protocol of a prospective randomized Phase III trial.
Sophie Piperno-Neumann, Leanne de Koning, Timothée Marchal, Lauris Gastaud, Lorraine Waechter, Manuel Rodrigues

Melanoma Manag· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis